Anticoagulation by factor Xa inhibitors
- 3 August 2010
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 8 (8), 1745-1753
- https://doi.org/10.1111/j.1538-7836.2010.03917.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- New AnticoagulantsCirculation, 2010
- The Nature of the Stable Blood Clot Procoagulant ActivitiesPublished by Elsevier ,2008
- Population pharmacokinetics and pharmacodynamics of once and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacementThrombosis and Haemostasis, 2008
- Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Rivaroxaban—an Oral, Direct Factor Xa Inhibitor—Are Not Affected by AspirinThe Journal of Clinical Pharmacology, 2006
- Development and Clinical Evaluation of Two Chromogenic Substrate Methods for Monitoring Fondaparinux SodiumTherapeutic Drug Monitoring, 2006
- The challenge of regulating anticoagulant drugs: Focus on warfarinAmerican Heart Journal, 2005
- Heparin and Calcium Ions Dramatically Enhance Antithrombin Reactivity with Factor IXa by Generating New Interaction ExositesBiochemistry, 2003
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Functional Characterization of Recombinant Human Meizothrombin and Meizothrombin(desF1)Journal of Biological Chemistry, 1997
- Purification of Six Human Vitamin K-Dependent Proteins in a Single Chromatographic Step Using Immunoaffinity Columns1Preparative Biochemistry, 1986